Enhanced In vivo human immunodeficiency virus-1 replication in the lungs of human immunodeficiency virus-infected persons with Pneumocystis carinii pneumonia

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 6, 1999, Pages 2048-2055

  Koziel, Henry ^a,b,c   Kim, Sue ^a,b   Reardon, Christine ^a,b   Li, Xiuhong ^a,b   Garland, Robert ^a,b   Pinkston, Paula ^a,b   Kornfeld, Hardy ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 16; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; ASPERGILLUS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM INTRACELLULARE AVIUM; NOCARDIA; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROVIRUS; T LYMPHOCYTE; VIRUS REPLICATION;

EID: 0033456218     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.6.9902099     Document Type: Article

References (26)

1. Hammer, S. M. 1996. Advances in antiretroviral therapy and viral load monitoring. AIDS 10:S1-S11.
2. Saag, M. S., M. Holodniy, D. R. Kuritzkes, W. A. O'Brien, R. Coombs, M. E. Poscher, D. M. Jacobsen, G. M. Shaw, D. D. Richman, and P. A. Volberding. 1996. HIV viral load markers in clinical practice. Nat. Med. 2:625-629.
3. Piatak, M., M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, K.-C. Luk, B. H. Hahn, G. M. Shaw, and J. D. Lifson. 1993. High levels of HIV-1 plasma during all stages of infection determined by competitive PCR. Science 259:1749-1754.
4. Mellors, J. W., C. R. Rinaldo, P. Gupta, R. M. White, J. A. Todd, and L. A. Kingsley. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170.
5. Ho, D. D. 1992. HIV-1 viremia and influenza. Lancet 339:1549.
6. Goletti, D., D. Weissman, R. W. Jackson, N. M. H. Graham, D. Vlahov, R. S. Klein, S. S. Munsiff, L. Ortona, R. Cauda, and A. S. Fauci. 1996. Effect of Mycobacterium tuberculosis on HIV replication: role of immune activation. J. Immunol. 157:1271-1278.
7. Donovan, R. M., C. Bush, N. Markowitz, D. Baxa, and L. Saravolatz. 1996. Changes in virus load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected persons. J. Infect. Dis. 174:401-403.
8. Lu, W., and D. Israel-Biet. 1993. Virion concentration in bronchoalveolar lavage fluids of HIV-infected patients. Lancet 342:298.
9. Nakata, K., W. N. Rom, Y. Honda, R. Condos, S. Kanegasaki, Y. Cao, and M. Weiden. 1997. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Am. J. Respir. Crit. Care Med. 155:996-1003.
10. Orenstein, J. M., C. Fox, and S. M. Wahl. 1997. Macrophages as a source of HIV during opportunistic infections. Science 276:1857-1861.
11. Koziel, H., Q. Eichbaum, B. A. Kruskal, P. Pinkston, R. A. Rogers, M. Y. K. Armstrong, F. F. Richards, R. M. Rose, and R. A. B. Ezekowitz. 1998. Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation. J. Clin. Invest. 102:1332-1344.
12. Rennard, S. I., G. Basset, D. Lecossier, K. M. O'Donnell, P. Pinkston, P. G. Martin, and R. G. Crystal. 1986. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J. Appl. Physiol. 60:532-538.
13. Ou, C. Y., S. Kwok, S. W. Mitchell, D. H. Mack, J. J. Sninsky, J. W. Krebs, P. Feorino, D. Warfield, and G. Schochetman. 1988. DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science 239:295-297.
14. Agostini, C., R. Zambello, L. Trentin, S. Garbisa, P. F. DiCelle, P. Bulian, M. Onisto, V. Poletti, L. Spiga, E. Raise, R. Foa, and G. Semenzato. 1991. Alveolar macrophages from patients with AIDS and AIDS-related complex constitutively synthesize and release tumor necrosis factor-α. Am. Rev. Respir. Dis. 144:195-201.
15. Agostini, C., L. Trentin, R. Zambello, P. Builian, C. Caenazzo, A. Cipriani, P. Candrobbi, S. Garbisa, and G. Semenzato. 1992. Release of granulocyte-macrophage colony-stimulating factor by alveolar macrophages in the lung of HIV-1-infected patients: a mechanism accounting for macrophage and neutrophil accumulation. J. Immunol. 149:3379-3385.
16. Duh, E., W. Maury, T. Folks, A. Fauci, and A. Rabon. 1989. Tumor necrosis factor-α activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-κβ sites in the long terminal repeat. Proc. Natl Acad Sci. U.S.A. 86:5974-5978.
17. Baier, M., A. Werner, N. Bannert, K. Metzner, and R. Kurth. 1995. HIV suppression by interleukin-16. Nature 378:563.
18. Maciaszek, J. W., N. Parada, W. W. Cruikshank, D. M. Center, H. Kornfeld, and G. A. Viglianti. 1997. Interleukin-16 represses HIV-1 promotor activity. J. Immunol. 158:5-8.
19. Pantaleo, G., C. Graziosi, J. F. Demarest, L. Butini, M. Montroni, C. H. Fox, J. M. Orenstein, D. P. Kotler, and A. S. Fauci. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355-358.
20. Tenner-Racz, K., H.-J. Stellbrink, J. V. Lunzen, C. Schneider, J.-P. Jacobs, B. R. Raschdorff, G. Großschupff, R. M. Steinman, and P. Racz. 1998. The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 cell proliferation: the impact of highly active antiretroviral therapy. J. Exp. Med. 187:949-959.
21. Rose, R. M., A. Krivine, P. Pinkston, J. M. Gillis, A. Huang, and S. M. Hammer. 1991. Frequent identification of HIV-1 DNA in bronchoalveolar lavage cells obtained from individuals with the acquired immunodeficiency syndrome. Am. Rev. Respir. Dis. 143:850-854.
22. Sierra-Madero, J., Z. Toossi, D. L. Hom, C. K. Finegan, E. Hoenig, and E. A. Rich. 1994. Relationship between load of virus in alveolar macrophages from human immunodeficiency virus type-1-infected persons, production of cytokines, and clinical status. J. Infect. Dis. 169:18-27.
23. Israel-Biet, D., J. Cadranel, and P. Even. 1993. Human immunodeficiency virus production by alveolar lymphocytes is increased during Pneumocystis carinii pneumonia. Am. Rev. Respir. Dis. 148:1308-1312.
24. Abbud, R. A., C. K. Finegan, L. A. Guay, and E. A. Rich. 1995. Enhanced production of human immunodeficiency virus type 1 by in vitro-infected alveolar macrophages from otherwise healthy cigarette smokers. J. Infect. Dis. 172:859-863.
25. Coffey, M. J., C. Woffendin, S. M. Phare, R. M. Strieter, and D. M. Markovitz. 1997. RANTES inhibits HIV-1 replication in human peripheral blood monocytes and alveolar macrophages. Am. J. Physiol. 272:L1025-L1029.
26. Marcy, T., W. Merrill, J. A. Rankin, and H. Reynolds. 1987. Limitations of using urea to quantify epithelial lining fluid recovered by bronchoalveolar lavage. Am. Rev. Respir. Dis. 135:1276-1280.